Quantbot Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.9K | Sell |
45
-305
| -87% | -$104K | ﹤0.01% | 1508 |
|
|
2025
Q4 | $139K | Sell |
350
-825
| -70% | -$365K | ﹤0.01% | 1339 |
|
|
2025
Q3 | $536K | Buy |
+1,175
| New | +$478K | 0.01% | 996 |
|
|
2025
Q1 | – | Sell |
-1,588
| Closed | -$374K | – | 1442 |
|
|
2024
Q4 | $374K | Buy |
1,588
+1,384
| +678% | +$364K | 0.01% | 906 |
|
|
2024
Q3 | $56.1K | Buy |
204
+193
| +1,755% | +$50.2K | ﹤0.01% | 1272 |
|
|
2024
Q2 | $2.67K | Sell |
11
-423
| -97% | -$66.8K | ﹤0.01% | 1360 |
|
|
2024
Q1 | $64.9K | Buy |
434
+115
| +36% | +$19.2K | ﹤0.01% | 1287 |
|
|
2023
Q4 | $61.1K | Buy |
+319
| New | +$54.3K | ﹤0.01% | 1300 |
|
|
2023
Q3 | – | Sell |
-699
| Closed | -$133K | – | 1505 |
|
|
2023
Q2 | $133K | Buy |
+699
| New | +$139K | 0.01% | 1103 |
|
|
2022
Q4 | – | Sell |
-679
| Closed | -$135K | – | 1637 |
|
|
2022
Q3 | $135K | Buy |
+679
| New | +$130K | 0.01% | 1013 |
|
|
2022
Q2 | – | Sell |
-3,806
| Closed | -$621K | – | 1668 |
|
|
2022
Q1 | $621K | Buy |
+3,806
| New | +$580K | 0.05% | 500 |
|
|
2021
Q3 | – | Sell |
-2,664
| Closed | -$451K | – | 1485 |
|
|
2021
Q2 | $451K | Buy |
+2,664
| New | +$390K | 0.04% | 579 |
|
|
2020
Q4 | – | Sell |
-1,229
| Closed | -$178K | – | 1251 |
|
|
2020
Q3 | $178K | Buy |
1,229
+1,122
| +1,049% | +$159K | 0.02% | 610 |
|
|
2020
Q2 | $15K | Buy |
107
+27
| +34% | +$3.64K | ﹤0.01% | 871 |
|
|
2020
Q1 | $8K | Sell |
80
-74
| -48% | -$8.54K | 0.01% | 705 |
|
|
2019
Q4 | $17K | Sell |
154
-45
| -23% | -$4.49K | ﹤0.01% | 1062 |
|
|
2019
Q3 | $16K | Sell |
199
-1,301
| -87% | -$103K | ﹤0.01% | 1133 |
|
|
2019
Q2 | $108K | Buy |
+1,500
| New | +$115K | 0.01% | 744 |
|
|
2019
Q1 | – | Sell |
-400
| Closed | -$29K | – | 983 |
|
|
2018
Q4 | $29K | Sell |
400
-346
| -46% | -$26.6K | ﹤0.01% | 879 |
|
|
2018
Q3 | $65K | Buy |
+746
| New | +$75K | ﹤0.01% | 987 |
|
|
2018
Q2 | – | Sell |
-2,682
| Closed | -$319K | – | 1171 |
|
|
2018
Q1 | $319K | Buy |
+2,682
| New | +$346K | 0.03% | 588 |
|
|
2017
Q3 | – | Sell |
-3,139
| Closed | -$250K | – | 1156 |
|
|
2017
Q2 | $250K | Buy |
3,139
+2,243
| +250% | +$143K | 0.02% | 613 |
|
|
2017
Q1 | $45K | Buy |
+896
| New | +$41.4K | ﹤0.01% | 926 |
|
|
2016
Q3 | – | Sell |
-4,882
| Closed | -$270K | – | 1057 |
|
|
2016
Q2 | $270K | Buy |
4,882
+925
| +23% | +$58.3K | 0.03% | 515 |
|
|
2016
Q1 | $248K | Buy |
3,957
+3,072
| +347% | +$204K | 0.04% | 476 |
|
|
2015
Q4 | $83K | Buy |
+885
| New | +$82.1K | 0.01% | 700 |
|
|
2015
Q2 | – | Sell |
-15
| Closed | -$1K | – | 1089 |
|
|
2015
Q1 | $1K | Sell |
15
-1,104
| -99% | -$112K | ﹤0.01% | 1010 |
|
|
2014
Q4 | $108K | Buy |
+1,119
| New | +$104K | 0.03% | 619 |
|
|
2013
Q4 | – | Sell |
-300
| Closed | -$19K | – | 964 |
|
|
2013
Q3 | $19K | Buy |
+300
| New | +$15K | 0.01% | 654 |
|
Other funds holding ALNY
VPM
VCM
Quantbot Technologies's ALNY Position: Q1 2026 in Review
Quantbot Technologies reduced its Alnylam Pharmaceuticals (ALNY) stake by 87% in Q1 2026, selling an estimated $104K and leaving 45 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.
Quantbot Technologies first reported a position in ALNY in Q3 2013 and has held it in 29 quarters since. The position peaked at $621K in Q1 2022. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.
- Quantbot Technologies held 45 shares of Alnylam Pharmaceuticals worth $14.9K as of Q1 2026.
- Quantbot Technologies sold 305 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $104K.
- Alnylam Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1508 holding.
- Quantbot Technologies first reported a position in Alnylam Pharmaceuticals in Q3 2013 and has held it in 29 quarters since.
- Quantbot Technologies's Alnylam Pharmaceuticals position peaked at $621K in Q1 2022.
- 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.